Skip links

Investing
in healthy
lifespans

quadraScope invests in healthcare companies developing pharmaceuticals, diagnostics, software, equipment and devices enabling disease treatment and prevention through biological age reversal.

Hallmarks of aging

Biogerontology is the new science that aims to extend human healthspan by addressing the biological basis of aging. It revolves around the concept of the Hallmarks of Aging, a framework introduced in 2013 by López-Otín et al. and further expanded in the paper Hallmarks of Aging: An Expanding Universe in 2023. The hallmarks of aging are shown below.

Genomic instability

Accumulation of DNA mutations due to failure of DNA repair mechanisms.

Telomere attrition

Shortening of the protective caps at the ends of chromosomes, leading to DNA damage and senescence.

Epigenetic alterations

Modifications in the way DNA is stored, read, and expressed, without altering the gene sequence.

Cellular senescence

Senescent cells are no loner able to divide, cannot die, and contribute to inflammation.

Mitochondrial dysfunction

Mitochondria, the energy-producing structures within cells, become leaky and inefficient.

Stem cell exhaustion

A decline in the number and function of stem cells, which are responsible for maintaining and repairing tissues.

Deregulated nutrient-sensing

Disruption of the mechanisms that control metabolism, utilization of nutrients, and  energy balance.

Loss of proteostasis

Failure to maintain protein quality and function, leading to the accumulation of damaged proteins.

Disabled macroautophagy

Decreased ability to break down and recycle damaged or unnecessary cellular parts.

Altered intercellular communication

Communication systems between cells become unstable and cells lose the ability to work together effectively.

Chronic inflammation

The immune system stays persistently active even when there is no infection to fight or injury to repair.

Dysbiosis

Unbalanced populations of microorganisms that live in the human body.

Portfolio

Rejuvenation of the immune system using the secretome of immune system stem cells
Learn more
Nanomachines (NaNots) that capture and remove harmful proteins from the bloodstream
Learn more
Cellular rejuvenation with initial focus on facial rejuvenation and enhancement of immune cells for CAR-T therapy
Learn more
Fix receding gums, facial aging, incontinence, and more via novel regenerative collagen
Learn more
Personalized medicine and drug discovery via a Machine Learning platform that models an individual’s state and history of health
Learn more
DNA fault detection and error correction platform to diagnose, prevent, and treat diseases associated with the loss of genetic information
Learn more
Treat pulmonary fibrosis and type II diabetes by boosting the immune system’s capacity to remove specific senescent cells
Learn more
Cholesterol degradation platform to reverse atherosclerosis and fatty liver disease
Learn more
Treating neurodegeneration, renal diseases, and other conditions by enhancing mitochondrial health through mitophagy
Learn more
Personalized healthcare platform using human organoids subjected to accelerated aging
Learn more
Franchise of clinics specializing in personalized rejuvenation treatments and offshore clinical trials
Learn more
Gene therapy using Klotho and other molecules to treat aging and Alzheimer’s disease
Learn more

Mechanism of action-based therapies for aging, with a focus on the role of lipids in metabolic diseaseLearn more

Aubrey de Grey, PhD

President & CSO, Longevity Escape Velocity Foundation

30-second video

Team

We are a women-led team with a strong track record of taking new ventures from inception to profitable exits, including a 12x exit, and deep understanding of the emerging longevity science and market.

Core team

Fiona Miller

Fiona Miller

Managing Partner
José Navarro-Betancourt, MD, PhD

José Navarro-Betancourt, MD, PhD

Scientific Director

Scientific advisory board

Nir Barzilai, MD

Nir Barzilai, MD

Venture Partner
Aubrey de Grey, PhD

Aubrey de Grey, PhD

Venture Partner
Carmela Abraham, PhD

Carmela Abraham, PhD

Venture Partner
Robert Cargill, PhD

Robert Cargill, PhD

Venture Partner
Diane Seimetz, PhD

Diane Seimetz, PhD

Venture Partner
Reason

Reason

Venture Partner
Nikola Markov, PhD

Nikola Markov, PhD

Venture Partner

Business advisory board

Miri Polachek

Miri Polachek

Venture Partner
Nico Helling

Nico Helling

Venture Partner
Frank Wellens

Frank Wellens

Venture Partner
Daniel Fylstra

Daniel Fylstra

Venture Partner
Lan Clark

Lan Clark

Venture Partner
José Cordeiro, PhD

José Cordeiro, PhD

Venture Partner

News and events